We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.7B
AUM Growth
+$3.07B
Cap. Flow
+$921M
Cap. Flow %
2.32%
Top 10 Hldgs %
13.97%
Holding
792
New
111
Increased
260
Reduced
279
Closed
96

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$212M
2
ABT icon
Abbott
ABT
+$143M
3
MS icon
Morgan Stanley
MS
+$138M
4
ITW icon
Illinois Tool Works
ITW
+$135M
5
GE icon
GE Aerospace
GE
+$114M

Sector Composition

Rank Sector Weight
1 Healthcare 14.15%
2 Technology 13.4%
3 Financials 12.89%
4 Industrials 11.08%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
576
DELISTED
Revance Therapeutics, Inc.
RVNC
$7.28M 0.02%
350,000
CERN
577
DELISTED
Cerner Corp
CERN
$7.09M 0.02%
120,420
-160,100
-57% -$8.65M
NWSA icon
578
News Corp Class A
NWSA
$15.6B
$7.04M 0.02%
541,441
-713
-0.1% -$8.93K
CSRA
579
DELISTED
CSRA Inc.
CSRA
$7.03M 0.02%
240,058
-228,773
-49% -$7.02M
TSE
580
DELISTED
Trinseo
TSE
$6.92M 0.02%
+103,200
New +$6.93M
TRIP icon
581
TripAdvisor
TRIP
$1.7B
$6.92M 0.02%
160,400
-2,300
-1% -$109K
BBBY
582
DELISTED
Bed Bath & Beyond Inc
BBBY
$6.92M 0.02%
175,381
-43,019
-20% -$1.73M
HRB icon
583
H&R Block
HRB
$5.98B
$6.82M 0.02%
293,200
-4,300
-1% -$96.2K
ANAB icon
584
AnaptysBio
ANAB
$1.54B
$6.8M 0.02%
+245,000
New +$5.71M
MTVA
585
MetaVia Inc
MTVA
$7.44M
$6.66M 0.02%
10
+4
+67% +$2.65M
RL icon
586
Ralph Lauren
RL
$22.4B
$6.59M 0.02%
+80,800
New +$6.67M
UHS icon
587
Universal Health Services
UHS
$10.2B
$6.41M 0.02%
51,500
+48,200
+1,461% +$5.7M
NAVI icon
588
Navient
NAVI
$819M
$6.32M 0.02%
428,406
-6,000
-1% -$92K
RGNX icon
589
Regenxbio
RGNX
$616M
$6.27M 0.02%
325,000
-25,000
-7% -$482K
WW
590
DELISTED
WW International
WW
$6.23M 0.02%
400,000
-200,000
-33% -$2.75M
KMT icon
591
Kennametal
KMT
$2.56B
$6.19M 0.02%
157,762
-468,925
-75% -$17.3M
MDGL icon
592
Madrigal Pharmaceuticals
MDGL
$12.6B
$6.16M 0.02%
400,000
+50,000
+14% +$786K
IMMU
593
DELISTED
Immunomedics Inc
IMMU
$6.15M 0.02%
+950,000
New +$4.81M
IPHI
594
DELISTED
INPHI CORPORATION
IPHI
$6.1M 0.02%
+125,000
New +$5.84M
SIG icon
595
Signet Jewelers
SIG
$3.84B
$6.02M 0.02%
86,881
-23,508
-21% -$1.76M
EME icon
596
Emcor
EME
$29.9B
$5.93M 0.01%
+94,132
New +$6.25M
GMED icon
597
Globus Medical
GMED
$11.1B
$5.92M 0.01%
+200,000
New +$5.46M
FBIN icon
598
Fortune Brands Innovations
FBIN
$5.86B
$5.91M 0.01%
+113,689
New +$5.57M
HOG icon
599
Harley-Davidson
HOG
$2.61B
$5.83M 0.01%
+96,400
New +$5.66M
DNB
600
DELISTED
Dun & Bradstreet
DNB
$5.62M 0.01%
52,107
+496
+1% +$56.2K

Similar funds

Adage Capital Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Adage Capital Partners held 792 positions worth $39.7B, up 8.4% from $36.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Adage Capital Partners's Q1 2017 filing shows 111 new, 260 increased, 279 reduced and 96 closed positions. Its largest new stake was American Express: 1,192,300 shares worth $94.3M. The largest sale was St Jude Medical, an estimated $276M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Adage Capital Partners's largest Q1 2017 buy was American Express: 1,192,300 shares worth $94.3M.
  • Adage Capital Partners added most to Deere & Co in Q1 2017, an estimated $212M increase.
  • Adage Capital Partners's biggest Q1 2017 reduction was Wells Fargo, cutting an estimated $225M.
  • Adage Capital Partners fully exited St Jude Medical in Q1 2017, selling an estimated $276M.
  • Adage Capital Partners's ten largest holdings make up 14% of its $39.7B portfolio in Q1 2017.
  • Adage Capital Partners opened 111 new positions and closed 96 in Q1 2017.
  • Adage Capital Partners's portfolio value rose 8.4% quarter-over-quarter to $39.7B.

Based on Adage Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.